nodes	percent_of_prediction	percent_of_DWPC	metapath
Mannitol—ABCB1—Cisplatin—bone cancer	0.168	0.431	CbGbCtD
Mannitol—ABCB1—Doxorubicin—bone cancer	0.113	0.289	CbGbCtD
Mannitol—ABCB1—Methotrexate—bone cancer	0.109	0.28	CbGbCtD
Mannitol—Hypoxia—Methotrexate—bone cancer	0.00427	0.007	CcSEcCtD
Mannitol—Phlebitis—Cisplatin—bone cancer	0.00417	0.00683	CcSEcCtD
Mannitol—Polyuria—Cisplatin—bone cancer	0.00409	0.0067	CcSEcCtD
Mannitol—Oral candidiasis—Epirubicin—bone cancer	0.004	0.00655	CcSEcCtD
Mannitol—Cardiac failure congestive—Cisplatin—bone cancer	0.00396	0.00648	CcSEcCtD
Mannitol—Lung disorder—Methotrexate—bone cancer	0.00383	0.00628	CcSEcCtD
Mannitol—Oral candidiasis—Doxorubicin—bone cancer	0.0037	0.00606	CcSEcCtD
Mannitol—Hyperventilation—Epirubicin—bone cancer	0.00369	0.00605	CcSEcCtD
Mannitol—Hyponatraemia—Cisplatin—bone cancer	0.0036	0.0059	CcSEcCtD
Mannitol—Lung disorder—Epirubicin—bone cancer	0.00359	0.00588	CcSEcCtD
Mannitol—Haemoptysis—Epirubicin—bone cancer	0.00343	0.00562	CcSEcCtD
Mannitol—Hyperventilation—Doxorubicin—bone cancer	0.00341	0.00559	CcSEcCtD
Mannitol—Dehydration—Cisplatin—bone cancer	0.00334	0.00547	CcSEcCtD
Mannitol—Lung disorder—Doxorubicin—bone cancer	0.00332	0.00544	CcSEcCtD
Mannitol—Nasopharyngitis—Cisplatin—bone cancer	0.00321	0.00526	CcSEcCtD
Mannitol—Haemoptysis—Doxorubicin—bone cancer	0.00317	0.0052	CcSEcCtD
Mannitol—Extravasation—Methotrexate—bone cancer	0.00311	0.0051	CcSEcCtD
Mannitol—Dysphonia—Epirubicin—bone cancer	0.00309	0.00506	CcSEcCtD
Mannitol—Extravasation—Epirubicin—bone cancer	0.00291	0.00477	CcSEcCtD
Mannitol—Dysphonia—Doxorubicin—bone cancer	0.00286	0.00468	CcSEcCtD
Mannitol—Renal failure—Cisplatin—bone cancer	0.00272	0.00446	CcSEcCtD
Mannitol—Stomatitis—Cisplatin—bone cancer	0.0027	0.00442	CcSEcCtD
Mannitol—Extravasation—Doxorubicin—bone cancer	0.00269	0.00441	CcSEcCtD
Mannitol—Skin exfoliation—Methotrexate—bone cancer	0.00259	0.00424	CcSEcCtD
Mannitol—Musculoskeletal pain—Epirubicin—bone cancer	0.00257	0.00421	CcSEcCtD
Mannitol—Eructation—Epirubicin—bone cancer	0.00249	0.00409	CcSEcCtD
Mannitol—Influenza like illness—Epirubicin—bone cancer	0.00247	0.00404	CcSEcCtD
Mannitol—Urinary tract disorder—Cisplatin—bone cancer	0.00245	0.00402	CcSEcCtD
Mannitol—Connective tissue disorder—Cisplatin—bone cancer	0.00244	0.004	CcSEcCtD
Mannitol—Urethral disorder—Cisplatin—bone cancer	0.00243	0.00399	CcSEcCtD
Mannitol—Skin exfoliation—Epirubicin—bone cancer	0.00242	0.00397	CcSEcCtD
Mannitol—Candida infection—Epirubicin—bone cancer	0.00242	0.00397	CcSEcCtD
Mannitol—Pulmonary oedema—Methotrexate—bone cancer	0.00241	0.00396	CcSEcCtD
Mannitol—Musculoskeletal pain—Doxorubicin—bone cancer	0.00238	0.0039	CcSEcCtD
Mannitol—Eructation—Doxorubicin—bone cancer	0.00231	0.00378	CcSEcCtD
Mannitol—Influenza like illness—Doxorubicin—bone cancer	0.00228	0.00374	CcSEcCtD
Mannitol—Thrombophlebitis—Methotrexate—bone cancer	0.00227	0.00373	CcSEcCtD
Mannitol—Diabetes mellitus—Methotrexate—bone cancer	0.00226	0.00371	CcSEcCtD
Mannitol—Pulmonary oedema—Epirubicin—bone cancer	0.00226	0.0037	CcSEcCtD
Mannitol—Polyuria—Methotrexate—bone cancer	0.00224	0.00368	CcSEcCtD
Mannitol—Skin exfoliation—Doxorubicin—bone cancer	0.00224	0.00368	CcSEcCtD
Mannitol—Candida infection—Doxorubicin—bone cancer	0.00224	0.00368	CcSEcCtD
Mannitol—Mediastinal disorder—Cisplatin—bone cancer	0.00224	0.00367	CcSEcCtD
Mannitol—Malnutrition—Cisplatin—bone cancer	0.00216	0.00354	CcSEcCtD
Mannitol—Phlebitis—Epirubicin—bone cancer	0.00214	0.00351	CcSEcCtD
Mannitol—Flatulence—Cisplatin—bone cancer	0.00213	0.00349	CcSEcCtD
Mannitol—Thrombophlebitis—Epirubicin—bone cancer	0.00213	0.00349	CcSEcCtD
Mannitol—Diabetes mellitus—Epirubicin—bone cancer	0.00212	0.00347	CcSEcCtD
Mannitol—Blood alkaline phosphatase increased—Epirubicin—bone cancer	0.00212	0.00347	CcSEcCtD
Mannitol—Pulmonary oedema—Doxorubicin—bone cancer	0.00209	0.00343	CcSEcCtD
Mannitol—Vision blurred—Cisplatin—bone cancer	0.00204	0.00334	CcSEcCtD
Mannitol—Cardiac failure congestive—Epirubicin—bone cancer	0.00203	0.00333	CcSEcCtD
Mannitol—Ill-defined disorder—Cisplatin—bone cancer	0.00201	0.00329	CcSEcCtD
Mannitol—Phlebitis—Doxorubicin—bone cancer	0.00198	0.00324	CcSEcCtD
Mannitol—Thrombophlebitis—Doxorubicin—bone cancer	0.00197	0.00323	CcSEcCtD
Mannitol—Blood alkaline phosphatase increased—Doxorubicin—bone cancer	0.00196	0.00321	CcSEcCtD
Mannitol—Diabetes mellitus—Doxorubicin—bone cancer	0.00196	0.00321	CcSEcCtD
Mannitol—Malaise—Cisplatin—bone cancer	0.00195	0.00319	CcSEcCtD
Mannitol—Cardiac failure—Epirubicin—bone cancer	0.00189	0.00309	CcSEcCtD
Mannitol—Cardiac failure congestive—Doxorubicin—bone cancer	0.00188	0.00308	CcSEcCtD
Mannitol—Convulsion—Cisplatin—bone cancer	0.00187	0.00307	CcSEcCtD
Mannitol—Hyponatraemia—Epirubicin—bone cancer	0.00185	0.00303	CcSEcCtD
Mannitol—Pain in extremity—Epirubicin—bone cancer	0.00184	0.00302	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.00183	0.00299	CcSEcCtD
Mannitol—Discomfort—Cisplatin—bone cancer	0.00182	0.00298	CcSEcCtD
Mannitol—Oedema—Cisplatin—bone cancer	0.00176	0.00289	CcSEcCtD
Mannitol—Infection—Cisplatin—bone cancer	0.00175	0.00287	CcSEcCtD
Mannitol—Cardiac failure—Doxorubicin—bone cancer	0.00175	0.00286	CcSEcCtD
Mannitol—Nervous system disorder—Cisplatin—bone cancer	0.00173	0.00283	CcSEcCtD
Mannitol—Tachycardia—Cisplatin—bone cancer	0.00172	0.00282	CcSEcCtD
Mannitol—Dehydration—Epirubicin—bone cancer	0.00171	0.00281	CcSEcCtD
Mannitol—Skin disorder—Cisplatin—bone cancer	0.00171	0.00281	CcSEcCtD
Mannitol—Hyponatraemia—Doxorubicin—bone cancer	0.00171	0.00281	CcSEcCtD
Mannitol—Pain in extremity—Doxorubicin—bone cancer	0.00171	0.00279	CcSEcCtD
Mannitol—Abdominal pain upper—Epirubicin—bone cancer	0.00168	0.00276	CcSEcCtD
Mannitol—Hypotension—Cisplatin—bone cancer	0.00165	0.0027	CcSEcCtD
Mannitol—Nasopharyngitis—Epirubicin—bone cancer	0.00165	0.0027	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Cisplatin—bone cancer	0.00161	0.00263	CcSEcCtD
Mannitol—Dehydration—Doxorubicin—bone cancer	0.00159	0.0026	CcSEcCtD
Mannitol—Upper respiratory tract infection—Methotrexate—bone cancer	0.00158	0.00259	CcSEcCtD
Mannitol—Dyspnoea—Cisplatin—bone cancer	0.00157	0.00258	CcSEcCtD
Mannitol—Abdominal pain upper—Doxorubicin—bone cancer	0.00156	0.00255	CcSEcCtD
Mannitol—Angina pectoris—Epirubicin—bone cancer	0.00155	0.00254	CcSEcCtD
Mannitol—Decreased appetite—Cisplatin—bone cancer	0.00153	0.00251	CcSEcCtD
Mannitol—Bronchitis—Epirubicin—bone cancer	0.00153	0.00251	CcSEcCtD
Mannitol—Nasopharyngitis—Doxorubicin—bone cancer	0.00152	0.0025	CcSEcCtD
Mannitol—Gastrointestinal disorder—Cisplatin—bone cancer	0.00152	0.0025	CcSEcCtD
Mannitol—Infestation NOS—Methotrexate—bone cancer	0.00152	0.00249	CcSEcCtD
Mannitol—Infestation—Methotrexate—bone cancer	0.00152	0.00249	CcSEcCtD
Mannitol—Pain—Cisplatin—bone cancer	0.00151	0.00247	CcSEcCtD
Mannitol—Renal failure—Methotrexate—bone cancer	0.00149	0.00244	CcSEcCtD
Mannitol—Upper respiratory tract infection—Epirubicin—bone cancer	0.00148	0.00243	CcSEcCtD
Mannitol—Stomatitis—Methotrexate—bone cancer	0.00148	0.00242	CcSEcCtD
Mannitol—Feeling abnormal—Cisplatin—bone cancer	0.00145	0.00238	CcSEcCtD
Mannitol—Angina pectoris—Doxorubicin—bone cancer	0.00144	0.00235	CcSEcCtD
Mannitol—Infestation NOS—Epirubicin—bone cancer	0.00142	0.00233	CcSEcCtD
Mannitol—Infestation—Epirubicin—bone cancer	0.00142	0.00233	CcSEcCtD
Mannitol—Bronchitis—Doxorubicin—bone cancer	0.00142	0.00232	CcSEcCtD
Mannitol—Renal failure—Epirubicin—bone cancer	0.0014	0.00229	CcSEcCtD
Mannitol—Body temperature increased—Cisplatin—bone cancer	0.00139	0.00229	CcSEcCtD
Mannitol—Stomatitis—Epirubicin—bone cancer	0.00138	0.00227	CcSEcCtD
Mannitol—Upper respiratory tract infection—Doxorubicin—bone cancer	0.00137	0.00224	CcSEcCtD
Mannitol—Pharyngitis—Methotrexate—bone cancer	0.00135	0.00222	CcSEcCtD
Mannitol—Urinary tract disorder—Methotrexate—bone cancer	0.00135	0.0022	CcSEcCtD
Mannitol—Urethral disorder—Methotrexate—bone cancer	0.00134	0.00219	CcSEcCtD
Mannitol—Infestation—Doxorubicin—bone cancer	0.00131	0.00215	CcSEcCtD
Mannitol—Infestation NOS—Doxorubicin—bone cancer	0.00131	0.00215	CcSEcCtD
Mannitol—Hypersensitivity—Cisplatin—bone cancer	0.0013	0.00213	CcSEcCtD
Mannitol—Renal failure—Doxorubicin—bone cancer	0.00129	0.00212	CcSEcCtD
Mannitol—Stomatitis—Doxorubicin—bone cancer	0.00128	0.0021	CcSEcCtD
Mannitol—Rhinitis—Epirubicin—bone cancer	0.00128	0.00209	CcSEcCtD
Mannitol—Asthenia—Cisplatin—bone cancer	0.00127	0.00207	CcSEcCtD
Mannitol—Pharyngitis—Epirubicin—bone cancer	0.00127	0.00207	CcSEcCtD
Mannitol—Urinary tract disorder—Epirubicin—bone cancer	0.00126	0.00206	CcSEcCtD
Mannitol—Connective tissue disorder—Epirubicin—bone cancer	0.00125	0.00205	CcSEcCtD
Mannitol—Urethral disorder—Epirubicin—bone cancer	0.00125	0.00205	CcSEcCtD
Mannitol—Mediastinal disorder—Methotrexate—bone cancer	0.00123	0.00201	CcSEcCtD
Mannitol—Chills—Methotrexate—bone cancer	0.00122	0.002	CcSEcCtD
Mannitol—Diarrhoea—Cisplatin—bone cancer	0.00121	0.00198	CcSEcCtD
Mannitol—Mental disorder—Methotrexate—bone cancer	0.00119	0.00196	CcSEcCtD
Mannitol—Malnutrition—Methotrexate—bone cancer	0.00119	0.00194	CcSEcCtD
Mannitol—Rhinitis—Doxorubicin—bone cancer	0.00118	0.00194	CcSEcCtD
Mannitol—Pharyngitis—Doxorubicin—bone cancer	0.00117	0.00192	CcSEcCtD
Mannitol—Urinary tract disorder—Doxorubicin—bone cancer	0.00116	0.00191	CcSEcCtD
Mannitol—Connective tissue disorder—Doxorubicin—bone cancer	0.00116	0.0019	CcSEcCtD
Mannitol—Urethral disorder—Doxorubicin—bone cancer	0.00116	0.0019	CcSEcCtD
Mannitol—Mediastinal disorder—Epirubicin—bone cancer	0.00115	0.00188	CcSEcCtD
Mannitol—Back pain—Methotrexate—bone cancer	0.00115	0.00188	CcSEcCtD
Mannitol—Chills—Epirubicin—bone cancer	0.00114	0.00187	CcSEcCtD
Mannitol—Vomiting—Cisplatin—bone cancer	0.00112	0.00184	CcSEcCtD
Mannitol—Vision blurred—Methotrexate—bone cancer	0.00112	0.00183	CcSEcCtD
Mannitol—Mental disorder—Epirubicin—bone cancer	0.00112	0.00183	CcSEcCtD
Mannitol—Rash—Cisplatin—bone cancer	0.00111	0.00182	CcSEcCtD
Mannitol—Dermatitis—Cisplatin—bone cancer	0.00111	0.00182	CcSEcCtD
Mannitol—Malnutrition—Epirubicin—bone cancer	0.00111	0.00182	CcSEcCtD
Mannitol—Ill-defined disorder—Methotrexate—bone cancer	0.0011	0.0018	CcSEcCtD
Mannitol—Flatulence—Epirubicin—bone cancer	0.00109	0.00179	CcSEcCtD
Mannitol—Nervousness—Epirubicin—bone cancer	0.00108	0.00177	CcSEcCtD
Mannitol—Back pain—Epirubicin—bone cancer	0.00107	0.00176	CcSEcCtD
Mannitol—Malaise—Methotrexate—bone cancer	0.00107	0.00175	CcSEcCtD
Mannitol—Vertigo—Methotrexate—bone cancer	0.00107	0.00175	CcSEcCtD
Mannitol—Mediastinal disorder—Doxorubicin—bone cancer	0.00106	0.00174	CcSEcCtD
Mannitol—Chills—Doxorubicin—bone cancer	0.00106	0.00173	CcSEcCtD
Mannitol—Nausea—Cisplatin—bone cancer	0.00105	0.00172	CcSEcCtD
Mannitol—Vision blurred—Epirubicin—bone cancer	0.00105	0.00171	CcSEcCtD
Mannitol—Cough—Methotrexate—bone cancer	0.00103	0.0017	CcSEcCtD
Mannitol—Mental disorder—Doxorubicin—bone cancer	0.00103	0.00169	CcSEcCtD
Mannitol—Ill-defined disorder—Epirubicin—bone cancer	0.00103	0.00169	CcSEcCtD
Mannitol—Convulsion—Methotrexate—bone cancer	0.00103	0.00168	CcSEcCtD
Mannitol—Malnutrition—Doxorubicin—bone cancer	0.00103	0.00168	CcSEcCtD
Mannitol—Flatulence—Doxorubicin—bone cancer	0.00101	0.00166	CcSEcCtD
Mannitol—Chest pain—Methotrexate—bone cancer	0.00101	0.00165	CcSEcCtD
Mannitol—Arthralgia—Methotrexate—bone cancer	0.00101	0.00165	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.001	0.00164	CcSEcCtD
Mannitol—Malaise—Epirubicin—bone cancer	0.001	0.00164	CcSEcCtD
Mannitol—Discomfort—Methotrexate—bone cancer	0.000998	0.00163	CcSEcCtD
Mannitol—Nervousness—Doxorubicin—bone cancer	0.000997	0.00163	CcSEcCtD
Mannitol—Vertigo—Epirubicin—bone cancer	0.000997	0.00163	CcSEcCtD
Mannitol—Back pain—Doxorubicin—bone cancer	0.000993	0.00163	CcSEcCtD
Mannitol—Cough—Epirubicin—bone cancer	0.000968	0.00159	CcSEcCtD
Mannitol—Vision blurred—Doxorubicin—bone cancer	0.000968	0.00159	CcSEcCtD
Mannitol—Convulsion—Epirubicin—bone cancer	0.000962	0.00158	CcSEcCtD
Mannitol—Infection—Methotrexate—bone cancer	0.000962	0.00158	CcSEcCtD
Mannitol—Hypertension—Epirubicin—bone cancer	0.000958	0.00157	CcSEcCtD
Mannitol—Ill-defined disorder—Doxorubicin—bone cancer	0.000953	0.00156	CcSEcCtD
Mannitol—Nervous system disorder—Methotrexate—bone cancer	0.000949	0.00156	CcSEcCtD
Mannitol—Arthralgia—Epirubicin—bone cancer	0.000945	0.00155	CcSEcCtD
Mannitol—Chest pain—Epirubicin—bone cancer	0.000945	0.00155	CcSEcCtD
Mannitol—Skin disorder—Methotrexate—bone cancer	0.00094	0.00154	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000938	0.00154	CcSEcCtD
Mannitol—Discomfort—Epirubicin—bone cancer	0.000934	0.00153	CcSEcCtD
Mannitol—Malaise—Doxorubicin—bone cancer	0.000926	0.00152	CcSEcCtD
Mannitol—Vertigo—Doxorubicin—bone cancer	0.000923	0.00151	CcSEcCtD
Mannitol—Oedema—Epirubicin—bone cancer	0.000906	0.00148	CcSEcCtD
Mannitol—Hypotension—Methotrexate—bone cancer	0.000904	0.00148	CcSEcCtD
Mannitol—Infection—Epirubicin—bone cancer	0.0009	0.00147	CcSEcCtD
Mannitol—Cough—Doxorubicin—bone cancer	0.000896	0.00147	CcSEcCtD
Mannitol—Convulsion—Doxorubicin—bone cancer	0.00089	0.00146	CcSEcCtD
Mannitol—Nervous system disorder—Epirubicin—bone cancer	0.000888	0.00146	CcSEcCtD
Mannitol—Hypertension—Doxorubicin—bone cancer	0.000887	0.00145	CcSEcCtD
Mannitol—Tachycardia—Epirubicin—bone cancer	0.000884	0.00145	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000882	0.00145	CcSEcCtD
Mannitol—Skin disorder—Epirubicin—bone cancer	0.00088	0.00144	CcSEcCtD
Mannitol—Chest pain—Doxorubicin—bone cancer	0.000874	0.00143	CcSEcCtD
Mannitol—Arthralgia—Doxorubicin—bone cancer	0.000874	0.00143	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000868	0.00142	CcSEcCtD
Mannitol—Discomfort—Doxorubicin—bone cancer	0.000864	0.00142	CcSEcCtD
Mannitol—Dyspnoea—Methotrexate—bone cancer	0.000863	0.00141	CcSEcCtD
Mannitol—Hypotension—Epirubicin—bone cancer	0.000846	0.00139	CcSEcCtD
Mannitol—Decreased appetite—Methotrexate—bone cancer	0.000841	0.00138	CcSEcCtD
Mannitol—Oedema—Doxorubicin—bone cancer	0.000838	0.00137	CcSEcCtD
Mannitol—Gastrointestinal disorder—Methotrexate—bone cancer	0.000836	0.00137	CcSEcCtD
Mannitol—Fatigue—Methotrexate—bone cancer	0.000834	0.00137	CcSEcCtD
Mannitol—Infection—Doxorubicin—bone cancer	0.000833	0.00136	CcSEcCtD
Mannitol—Pain—Methotrexate—bone cancer	0.000828	0.00136	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000825	0.00135	CcSEcCtD
Mannitol—Nervous system disorder—Doxorubicin—bone cancer	0.000822	0.00135	CcSEcCtD
Mannitol—Tachycardia—Doxorubicin—bone cancer	0.000818	0.00134	CcSEcCtD
Mannitol—Skin disorder—Doxorubicin—bone cancer	0.000814	0.00133	CcSEcCtD
Mannitol—Dyspnoea—Epirubicin—bone cancer	0.000808	0.00132	CcSEcCtD
Mannitol—Feeling abnormal—Methotrexate—bone cancer	0.000798	0.00131	CcSEcCtD
Mannitol—Decreased appetite—Epirubicin—bone cancer	0.000787	0.00129	CcSEcCtD
Mannitol—Hypotension—Doxorubicin—bone cancer	0.000783	0.00128	CcSEcCtD
Mannitol—Gastrointestinal disorder—Epirubicin—bone cancer	0.000782	0.00128	CcSEcCtD
Mannitol—Fatigue—Epirubicin—bone cancer	0.000781	0.00128	CcSEcCtD
Mannitol—Pain—Epirubicin—bone cancer	0.000775	0.00127	CcSEcCtD
Mannitol—Urticaria—Methotrexate—bone cancer	0.000769	0.00126	CcSEcCtD
Mannitol—Body temperature increased—Methotrexate—bone cancer	0.000765	0.00125	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000764	0.00125	CcSEcCtD
Mannitol—Dyspnoea—Doxorubicin—bone cancer	0.000747	0.00122	CcSEcCtD
Mannitol—Feeling abnormal—Epirubicin—bone cancer	0.000746	0.00122	CcSEcCtD
Mannitol—Decreased appetite—Doxorubicin—bone cancer	0.000729	0.00119	CcSEcCtD
Mannitol—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000724	0.00119	CcSEcCtD
Mannitol—Fatigue—Doxorubicin—bone cancer	0.000723	0.00118	CcSEcCtD
Mannitol—Urticaria—Epirubicin—bone cancer	0.00072	0.00118	CcSEcCtD
Mannitol—Pain—Doxorubicin—bone cancer	0.000717	0.00117	CcSEcCtD
Mannitol—Body temperature increased—Epirubicin—bone cancer	0.000716	0.00117	CcSEcCtD
Mannitol—Hypersensitivity—Methotrexate—bone cancer	0.000713	0.00117	CcSEcCtD
Mannitol—Asthenia—Methotrexate—bone cancer	0.000694	0.00114	CcSEcCtD
Mannitol—Feeling abnormal—Doxorubicin—bone cancer	0.000691	0.00113	CcSEcCtD
Mannitol—Pruritus—Methotrexate—bone cancer	0.000685	0.00112	CcSEcCtD
Mannitol—Hypersensitivity—Epirubicin—bone cancer	0.000667	0.00109	CcSEcCtD
Mannitol—Urticaria—Doxorubicin—bone cancer	0.000666	0.00109	CcSEcCtD
Mannitol—Body temperature increased—Doxorubicin—bone cancer	0.000663	0.00109	CcSEcCtD
Mannitol—Diarrhoea—Methotrexate—bone cancer	0.000662	0.00109	CcSEcCtD
Mannitol—Asthenia—Epirubicin—bone cancer	0.00065	0.00107	CcSEcCtD
Mannitol—Pruritus—Epirubicin—bone cancer	0.000641	0.00105	CcSEcCtD
Mannitol—Dizziness—Methotrexate—bone cancer	0.00064	0.00105	CcSEcCtD
Mannitol—Diarrhoea—Epirubicin—bone cancer	0.00062	0.00102	CcSEcCtD
Mannitol—Hypersensitivity—Doxorubicin—bone cancer	0.000617	0.00101	CcSEcCtD
Mannitol—Vomiting—Methotrexate—bone cancer	0.000615	0.00101	CcSEcCtD
Mannitol—Rash—Methotrexate—bone cancer	0.00061	0.001	CcSEcCtD
Mannitol—Dermatitis—Methotrexate—bone cancer	0.00061	0.000999	CcSEcCtD
Mannitol—Headache—Methotrexate—bone cancer	0.000606	0.000994	CcSEcCtD
Mannitol—Asthenia—Doxorubicin—bone cancer	0.000601	0.000985	CcSEcCtD
Mannitol—Dizziness—Epirubicin—bone cancer	0.000599	0.000982	CcSEcCtD
Mannitol—Pruritus—Doxorubicin—bone cancer	0.000593	0.000972	CcSEcCtD
Mannitol—Vomiting—Epirubicin—bone cancer	0.000576	0.000944	CcSEcCtD
Mannitol—Nausea—Methotrexate—bone cancer	0.000575	0.000942	CcSEcCtD
Mannitol—Diarrhoea—Doxorubicin—bone cancer	0.000573	0.00094	CcSEcCtD
Mannitol—Rash—Epirubicin—bone cancer	0.000571	0.000936	CcSEcCtD
Mannitol—Dermatitis—Epirubicin—bone cancer	0.000571	0.000935	CcSEcCtD
Mannitol—Headache—Epirubicin—bone cancer	0.000567	0.00093	CcSEcCtD
Mannitol—Dizziness—Doxorubicin—bone cancer	0.000554	0.000908	CcSEcCtD
Mannitol—Nausea—Epirubicin—bone cancer	0.000538	0.000882	CcSEcCtD
Mannitol—Vomiting—Doxorubicin—bone cancer	0.000533	0.000873	CcSEcCtD
Mannitol—Rash—Doxorubicin—bone cancer	0.000528	0.000866	CcSEcCtD
Mannitol—Dermatitis—Doxorubicin—bone cancer	0.000528	0.000865	CcSEcCtD
Mannitol—Headache—Doxorubicin—bone cancer	0.000525	0.00086	CcSEcCtD
Mannitol—Nausea—Doxorubicin—bone cancer	0.000498	0.000816	CcSEcCtD
